Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

Eli Lilly raised its full-year profit and sales forecast on Thursday, betting on surging demand for its blockbuster ...

Digestion issues, fatigue, and high costs haven’t stopped some from finding power and transformation through GLP-1 ...

Medicare covers weight loss drugs including Ozempic under specific conditions when the drug also has potential use cases beyond weight loss.

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

Eli Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.

Conditions treated: Zepbound and Wegovy are both used for weight loss and weight management. But each drug also has other uses. (See the “Uses of Zepbound vs. Wegovy” section for details.) ...

Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says By Jen Christensen, CNN, CNNWire Wednesday, April 17, 2024 ...